Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Boots Alliance (Nasdaq: WBA) has declared a quarterly dividend of 46.75 cents per share, maintaining the previous quarter's amount and marking a 2.2% increase from last year. The dividend is payable on March 12, 2021, to shareholders on record as of February 19, 2021. WBA has consistently paid dividends for 353 quarters and raised them for 45 consecutive years, reflecting strong financial stability and commitment to returning value to shareholders.
Walgreens Boots Alliance (Nasdaq: WBA) appointed Roz Brewer as CEO effective March 15, 2021, succeeding Stefano Pessina, who transitions to Executive Chairman. Brewer, previously COO at Starbucks, brings expertise in digital transformation and operational leadership. Her appointment follows a detailed search to leverage WBA's growth opportunities in healthcare. The board anticipates Brewer's focus on customer experience and operational rigor will drive sustainable growth. Skinner, the outgoing chairman, emphasized WBA's strong position in community healthcare, expressing confidence in the future under Brewer's leadership.
Walgreens has successfully administered over 1 million COVID-19 vaccinations across vulnerable populations, including long-term care facilities. As part of the CDC Pharmacy Partnership, vaccinations began on Dec. 21 and are set to complete first doses in skilled nursing facilities by Jan. 25. Walgreens aims to provide access to those prioritized by state and jurisdiction guidelines, with current eligibility focusing on healthcare workers and individuals aged 65 and older. The company continues to follow strict federal and state protocols for vaccination reporting.
Walgreens Boots Alliance (Nasdaq: WBA) will host its virtual annual stockholders' meeting on Jan. 28, 2021, at 8:00 a.m. CST, accessible via their investor relations website. A live audio webcast will be available, with a replay archived for 12 months. Executive Chairman Jim Skinner and CEO Stefano Pessina will present, followed by a Q&A session for attendees. WBA, a global leader in pharmacy and healthcare, operates over 21,000 stores in more than 25 countries, focusing on community health and sustainability.
No7 announces the launch of its latest product, Laboratories Resurfacing Peel 15% Glycolic Acid, aimed at providing an at-home alternative to professional dermatological treatments. The peel utilizes glycolic acid, known for its exfoliating properties, along with gluconolactone for improved efficacy and skin tolerance. Dermatologist Dr. Tess Mauricio endorses the product, noting visible improvements in skin texture and tone after usage. The peel retails for $39.99 and is available online.
Walgreens has issued a statement in response to President-elect Biden’s COVID-19 Update, expressing support for his plan to boost vaccine distribution through pharmacies. Walgreens cites its extensive network and experience, stating it is well-positioned to administer COVID-19 vaccines across the nation. The company has been vaccinating vulnerable populations in long-term care facilities since December and is ready to broaden its vaccine efforts in local communities. Walgreens aims to provide convenient and equitable access to vaccines for all Americans.
OFP Real Estate, LLC has acquired a net-leased investment property tenanted by Walgreens Boots Alliance (WBA) in the Cleveland, Ohio metro area. This acquisition, which marks OFP's first for 2021, was secured with a long-term lease, ensuring stable and predictable returns. The purchase increases OFP's net-lease investments to over $45,000,000 across five states, with aims to exceed a $150,000,000 acquisition target by year-end. The firm focuses on income-producing investments from leading retail tenants.
Walgreens is enhancing its financial services by partnering with Synchrony and Mastercard to launch credit and prepaid debit cards. These offerings will integrate with the myWalgreens loyalty program, providing customers with cash rewards and additional benefits at over 9,000 Walgreens locations and beyond. The cards aim to boost customer engagement and create new revenue streams, with features like contactless payments and health-focused rewards. The new financial products are expected to be available in the second half of this year, reflecting Walgreens' commitment to improving health and wellness payment solutions.
Walgreens Boots Alliance (Nasdaq: WBA) has announced a majority investment in iA, a provider of software-enabled automation solutions for the pharmacy sector. This strategic investment aims to enhance iA's pharmacy automation offerings, thus streamlining medication dispensing and enabling pharmacists to focus more on patient care. The move aligns with the growing demand for efficient healthcare solutions, especially post-COVID-19, aiming to modernize pharmacy operations and improve patient outcomes.
Walgreens Boots Alliance (WBA) reported first-quarter fiscal 2021 results, with sales of $36.3 billion, a 5.7% increase from the prior year. Despite strong sales, the company faced an operating loss of $440 million, largely due to a $1.5 billion equity charge from AmerisourceBergen. Net loss was $308 million, with adjusted EPS down 11.2% to $1.22. The company maintains its fiscal 2021 guidance for low single-digit growth in adjusted earnings per share. Walgreens continues its critical role in COVID-19 vaccinations, with over 2.8 million tests administered.